Departments

From the Deputy Director for Intramural Research

My Time as Deputy Director for Intramural Research: What the Future Holds

I’m excited that the next Deputy Director for Intramural Research (DDIR) will bring new energy to NIH’s intramural research program (IRP). In preparation for the transition to new leadership—including a new NIH Director—I have worked closely with NIH scientific and clinical directors to identify four areas of challenges and opportunities that will need to be addressed.

News Brief

Norman Sharpless Steps Down as Director of the National Cancer Institute

Norman E. “Ned” Sharpless announced in early April that he has decided to step down from his position as director of the National Cancer Institute (NCI), a position he has held since 2017.

Research Briefs

Read about NIH scientific advances and discoveries by intramural scientists: complete human genome sequenced; hydration may reduce long-term cardiac risk; peripheral vision attention not driven by tiny eye movements; targeting fat-cell signaling may help treat metabolic disease; newly discovered molecular pathway in two neurodegenerative disorders; and machine learning successfully identifies ALS subtypes.

Technology Transfer

NCI’s Quest for a Successful HIV Vaccine

Clinical Trial on the Way

Since the beginning of the AIDS epidemic in the 1980s, scientists at the National Cancer Institute (NCI) have made several pivotal discoveries in HIV and AIDS and AIDS-associated cancers. Four decades later, NCI senior investigator Genoveffa Franchini is close to finding a vaccine approach to prevent HIV infection and AIDS.

Colleagues: Recently Tenured

Meet your recently tenured colleagues: Clint T. Allen (NIDCD), John Brognard (NCI-CCR), Jonathan Hofmann (NCI-DCEG), Yuichi Machida (NCI-CCR), and Quan Yuan (NINDS, pictured)

From the Fellows Committee

Training Opportunities in Tech Transfer

Many fellows at the NIH share an interest in developing innovative new drug targets, diagnostics, therapies, and technologies and finding ways to move them from the bench to the bedside. But what does it take to bring innovations into the public realm? The answer often lies in technology transfer.

From the Annals of NIH History

Biologics Regulation and Research

The People and Work of Buildings 29 and 29A

Two soon-to-be demolished buildings—the Biologics Standards Laboratory Building (Building 29) and the Biologics Standards Laboratory Annex (Building 29A)—are nationally significant to the history of medicine and public health. They will live on in a new website hosted by the Office of NIH History and Stetten Museum.

Photographic Moment

HIV-Infected and Uninfected Immune Cells Interact

Three-dimensional structure of HIV-infected and uninfected T cells interacting.

News From and About the Scientific Interest Groups

Two new SIGS: The Consciousness Research Interest Group will provide a platform to discuss, discover, collaborate, and stimulate the research of the science of consciousness; the Metastasis Scientific Interest Group will support metastasis-related research at the NIH.

Announcements

News about May 24 PBS documentary that features NIH founder; events, deadlines, lectures, and more.